Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cystic Fibrosis: Pathogenesis

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...

Cystic Fibrosis: Management

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...

Pulmonary Tuberculosis II

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...

Diversity of Protists II

Diversity of Protists II

Alveolates are a group of organisms recognized by the presence of alveoli, which are cytoplasmic sacs located beneath the cell membrane. While their function remains uncertain, alveoli may help regulate water balance by controlling how much water enters and leaves the cell. In dinoflagellates, these structures may serve as armor plates. There are three major types of alveolates: ciliates, which move using cilia; dinoflagellates, which use flagella for movement; and apicomplexans, which are...

Cytomegalovirus Disease

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Prevalence and Associated Clinical Factors of Tuberculosis Infection and Disease Among Pediatric Household Contacts: A Facility-Based Cross-Sectional Study.

Cureus·2026

Same author

Iatrogenic Bile Duct Injury in 2025: Real World Causes, Referral Patterns, and Reconstruction Outcomes From a Tertiary Care Centre in a Sub-himalayan Region.

Cureus·2026

Same author

Antenatal oral fetus in fetu with a mandibular defect: A case report.

Ultrasound (Leeds, England)·2026

Same author

Outcomes of Nonthermal and Nontumescent Endovenous Glue Ablation for Treatment of Incompetent Truncal Veins in Symptomatic Varicose Vein Disease in Indian Population.

Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists·2026

Same author

Primary Breast Lymphoma: A Rare but Important Differential Diagnosis in Patients with Breast Malignancy.

South Asian journal of cancer·2025

Same author

Engineered antibodies that stabilize drug-modified KRAS<sup>G12C</sup> neoantigens enable selective and potent cross-HLA immunotherapy.

Nature communications·2025

Search research articles

Related Experiment Video

Updated: Mar 23, 2026

Transient Transduction of the Strobilated Forms of Echinococcus granulosus

Transient Transduction of the Strobilated Forms of Echinococcus granulosus

Published on: September 16, 2022

Cystic pulmonary hydatidosis.

Malay Sarkar¹, Rajnish Pathania², Anupam Jhobta³

¹Department of Pulmonary Medicine, Indira Gandhi Medical College, Shimla, Himachal Pradesh, India.

Lung India : Official Organ of Indian Chest Society

|April 7, 2016

Summary

Cystic echinococcosis (CE) is a parasitic disease causing pulmonary hydatid cysts globally. This review covers CE pathogenesis, lifecycle, clinical features, and management, including surgery and benzimidazoles.

Keywords:

Benzimidazoles Echinococcus granulosus cystic echinococcosis water-lily sign

More Related Videos

Isolation And Dendritic Cell-Uptake of Small Extracellular Vesicles from Echinococcus granulosus

Isolation And Dendritic Cell-Uptake of Small Extracellular Vesicles from Echinococcus granulosus

Published on: March 28, 2025

Generation and Quantitative Characterization of Functional and Polarized Biliary Epithelial Cysts

Generation and Quantitative Characterization of Functional and Polarized Biliary Epithelial Cysts

Published on: May 16, 2020

Related Experiment Videos

Last Updated: Mar 23, 2026

Transient Transduction of the Strobilated Forms of Echinococcus granulosus

Transient Transduction of the Strobilated Forms of Echinococcus granulosus

Published on: September 16, 2022

Isolation And Dendritic Cell-Uptake of Small Extracellular Vesicles from Echinococcus granulosus

Isolation And Dendritic Cell-Uptake of Small Extracellular Vesicles from Echinococcus granulosus

Published on: March 28, 2025

Generation and Quantitative Characterization of Functional and Polarized Biliary Epithelial Cysts

Generation and Quantitative Characterization of Functional and Polarized Biliary Epithelial Cysts

Published on: May 16, 2020

Area of Science:

Parasitology
Infectious Diseases
Public Health

Background:

Cystic echinococcosis (CE) is a zoonotic parasitic disease caused by Echinococcus granulosus.
Pulmonary hydatid cysts represent a significant global health burden, impacting medical, social, and economic aspects.
Understanding the disease's lifecycle and transmission is crucial for control.

Purpose of the Study:

To provide a comprehensive overview of pulmonary hydatid disease.
To detail the pathogenesis, lifecycle, clinical manifestations, and management strategies for CE.
To consolidate current knowledge for clinicians and researchers.

Main Methods:

This is a review article, synthesizing existing literature.
Information was gathered from scientific databases and relevant publications.
Focus is on established knowledge regarding pathogenesis, lifecycle, clinical features, and treatment.

Main Results:

Pulmonary hydatidosis results from Echinococcus granulosus larval infection.
Clinical presentation varies, often asymptomatic until complications arise.
Surgical intervention is the primary treatment, with benzimidazoles as an alternative for specific cases.

Conclusions:

Pulmonary hydatid disease requires a thorough understanding of its multifaceted nature.
Effective management hinges on accurate diagnosis and appropriate therapeutic choices, including surgery or pharmacotherapy.
Continued research and public health initiatives are vital for controlling this zoonotic disease.